TITLE

Akorn Reports Record 3rd Qtr 2011 Financial Results

PUB. DATE
November 2011
SOURCE
Biomedical Market Newsletter;11/7/2011, Vol. 21, p799
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the financial statements of Lake Forest, Illinois-based Akorn Inc. for the third quarter ended September 30, 2011. It says that the company reported an increase of consolidated revenue by 69% to 36.7 million dollars. It notes that Akorn achieved a net income of 13.5 million dollars and earnings per share of 0.13 dollar per diluted share.
ACCESSION #
69589508

 

Related Articles

  • AmerisourceBergen Reports $0.54 Diluted EPS, Up 8.0%%, and Record Revenue of $20.4 Bln in the Sept Quarter.  // Biomedical Market Newsletter;11/7/2011, Vol. 21, p789 

    The article reports on the financial statements of Valley Forge, Pennsylvania-based AmerisourceBergen Corp. for the fourth quarter ended September 30, 2011. It says that the company recorded an increase of diluted earnings per share (EPS) by 8.0% to 0.54 dollar, while its revenue rose by 3.5% to...

  • Amedisys Reports 3rd Qtr Financial Results.  // Biomedical Market Newsletter;11/7/2011, Vol. 21, p792 

    The article reports on the financial statements of Baton Rouge, Louisiana-based Amedisys Inc. for the third quarter ended September 30, 2011. It says that the company reported an estimated noncash goodwill and other tangible assets impairment charge of 574.1 million dollars as of the said...

  • Akorn. Investor's Business Daily // Investors Business Daily;5/ 7/2014, pA02 

    The article reports on the 23% to 16 cents increase in earning per share (EPS) of pharmaceutical company Akorn in the first quarter (Q1) of 2014.

  • Setting the norms.  // Finance Week;Mar2004 Review Supplement, p10 

    Discusses components of published consolidated audited financial statements in South Africa. Internal rate of return; Gold and financial companies; Total assets; Net profit; Equity funds; Earnings per share; Dividend per share; Interest cover; Market capitalization.

  • Be prepared! Holgate, Peter // Accountancy;Dec1997, Vol. 120 Issue 1252, p55 

    Focuses on Financial Reporting Exposure Draft 16 'Earnings Per Share' in Great Britain. Treatment of options in calculating the diluted earnings per share figure.

  • Q3 Pharma Profits Mostly Miss. Investor's Business Daily // Investors Business Daily;11/10/2014, pB02 

    8

  • Akorn Rebounds As New Pattern Now Takes Shape. ANDREW EDWARDS // Investors Business Daily;12/10/2014, pB08 

    Sector Leaders warrant special attention due to their record of outperformance. That's why IBD prominently features these stocks with information-packed mini charts and analysis each day.

  • ANALYSTS' CHOICE Altria to unlock value.  // Dow Theory Forecasts;11/22/2004, Vol. 60 Issue 47, p8 

    Presents an investment analysis for Altria. Subsidiaries of the company that make cigarettes and packaged foods; Earnings per share of the company in September; Unit sales of the subsidiaries.

  • SURMODICS REPORTS 2ND QTR '06 RECORD REVENUE OF $17.7 MIL.  // Biotech Financial Reports;Jun2006, p7 

    The article reports about the second quarter 2006 revenue of SurModics Inc. Revenue for the second quarter of fiscal 2006 was $17.7 million which an increase of 13% from $15.7 million in the previous year. On a GAAP basis, operating income was $9.0 million; net income was $1.5 million; and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics